Haitong Securities Company Limited(600837)
About Hvsen Biotechnology Co.Ltd(300871)
Verification opinions on the deposit and use of raised funds in 2021
Haitong Securities Company Limited(600837) (hereinafter referred to as ” Haitong Securities Company Limited(600837) ” or “sponsor”) as a sponsor of Hvsen Biotechnology Co.Ltd(300871) (hereinafter referred to as ” Hvsen Biotechnology Co.Ltd(300871) ” or “company”) issuing convertible corporate bonds to unspecified objects, According to the measures for the administration of securities issuance and listing recommendation business, the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies (revised in 2022), the Listing Rules of GEM stocks of Shenzhen Stock Exchange and the guidelines for the self-discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of GEM listed companies And other relevant regulations, carefully and prudently checked the deposit and use of the raised funds in Hvsen Biotechnology Co.Ltd(300871) 2021. 1、 Basic information of raised funds
(I) actual amount of raised funds and time of fund arrival
1. Initial public offering of shares to raise funds
With the approval of registration of Hvsen Biotechnology Co.Ltd(300871) initial public offering issued by China Securities Regulatory Commission (zjxk [2020] No. 1586), the company publicly issued 27700000 ordinary shares in RMB to the public in August 2020, with a par value of 1.00 yuan per share, an issue price of 33.61 yuan per share and a total raised capital of 93099700000 yuan, After deducting 6336772639 yuan of recommendation and underwriting fee (excluding tax), the raised fund is 86762927361 yuan. In addition, after deducting 1691675281 yuan of issuance expenses excluding tax, such as audit and verification fees, lawyer fees, information disclosure fees and notarization fees, the net amount of raised funds is 85071252080 yuan. All the above raised funds were received on August 17, 2020 and verified by Zhongshen Zhonghuan Certified Public Accountants (special general partnership), and a capital verification report of Zhonghuan Yanzi [2020] No. 010051 was issued.
2. Issue convertible corporate bonds to unspecified objects
With the approval of registration of Hvsen Biotechnology Co.Ltd(300871) issuing convertible corporate bonds to unspecified objects (zjxk [2021] No. 3570) issued by China Securities Regulatory Commission, the company issued 7 million convertible corporate bonds to unspecified objects, with a face value of 100 yuan each and a total raised capital of 700 million yuan. After deducting the underwriting recommendation fee of RMB 855660377 (excluding tax) from the issuance of convertible corporate bonds to unspecified objects, the raised funds of RMB 69144339623 were transferred to the special storage account of raised funds designated by the company on December 23, 2021. After deducting the underwriting and recommendation fees, audit and capital verification fees, lawyer fees, credit rating fees and other fees totaling 1070098287 yuan (excluding tax), the total amount of funds raised from the issuance of convertible corporate bonds to unspecified objects will be 68929901713 yuan. Zhongshen Zhonghuan Certified Public Accountants (special general partnership) issued Zhonghuan Yanzi [2021] No. 0100097 verification report on funds raised by Wuhan Hvsen Biotechnology Co.Ltd(300871) Technology Co., Ltd. by issuing convertible corporate bonds on December 23, 2021.
(II) use and balance of raised funds
1. As of December 31, 2021, the use and balance of funds raised by the company’s initial public offering are as follows:
Project amount (RMB)
The net amount of raised funds received in 2020 was 85071252080
Plus: the amount of interest income deducting handling charges is 877437526
Financial income from idle raised funds 28 Offshore Oil Engineering Co.Ltd(600583) 8
Less: 63102319329 accumulated investment in projects invested with raised funds
Including: construction project of powder / powder / premix automatic production base in Xingou base 21870875133
Xingou base R & D and quality inspection center construction project 5655506895
Construction project of 1600t / a tylosin fermentation production base 6997314447
Traditional Chinese medicine extraction and preparation production line construction project Beijing Jingcheng Machinery Electric Company Limited(600860) 1256
Over raised funds: 2257 Wuhan Sante Cableway Group Co.Ltd(002159) 8 of tylosin project with an annual output of 1000 tons
Supplementary working capital 7000000000
As of December 31, 2021, the balance of the special account for raised funds was 16132376115
2. As of December 31, 2021, the company issued convertible corporate bonds to unspecified objects, and the fund use and balance are as follows:
Project amount (RMB)
Total amount of raised funds 700 million.00
Underwriting fee: 8556603
Capital amount (note) 14433961
Plus: interest income deducting handling fee 26459234
As of December 31, 2021, the balance of the special account for raised funds was 69170798857
Note 1: the difference between the amount of 69144339623 and the net amount of 68929901713 yuan is due to the use of self owned funds to pay part of the issuance expenses
As of December 31, 2021, the balance of funds raised by the company’s initial public offering of shares in 2020 was 1613238 million yuan (including interest income and financial management income), the balance of funds raised by the company’s issuance of convertible corporate bonds to unspecified objects in 2021 was 691708 million yuan (including interest income), and the total amount of unused raised funds was 8530318 million yuan, All funds shall be deposited in the special account for raised funds.
2、 Deposit and management of raised funds
(I) management of raised funds
In order to standardize the management of the company’s raised funds, improve the use efficiency of the raised funds and effectively protect the legitimate rights and interests of shareholders, In accordance with the company law, the securities law, the Interim Measures for the administration of initial public offering and listing on the gem, the measures for the administration of securities issuance of listed companies, the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds of listed companies (revised in 2022), and the Listing Rules of GEM stocks of Shenzhen Stock Exchange The management system of Hvsen Biotechnology Co.Ltd(300871) raised funds (hereinafter referred to as the “management system”) is formulated in combination with the actual situation of the company, such laws, regulations, rules and normative documents as the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on GEM, as well as the relevant provisions of the articles of association.
(II) supervision agreement of raised funds
According to the requirements of the management system and in combination with the company’s business needs, the company implements a special account for the funds raised by the initial public offering, and implements strict approval procedures for the use of the raised funds to ensure that the special funds are used for special purposes. Upon deliberation and approval at the 8th meeting of the second board of directors of the company, on August 27, 2020, the company together with the sponsor Haitong Securities Company Limited(600837) (hereinafter referred to as ” Haitong Securities Company Limited(600837) “) and the Bank of Hankou Co., Ltd. Wuchang sub branch, China Merchants Bank Co.Ltd(600036) Wuhan Dongxihu sub branch, China Citic Bank Corporation Limited(601998) Wuhan Branch Agricultural Bank Of China Limited(601288) Yingcheng sub branch signed the tripartite supervision agreement on the funds raised by initial public offering.
Approved by the ninth meeting of the second board of directors of the company, on September 10, 2020, the company and its subordinates
Hubei Hvsen Biotechnology Co.Ltd(300871) Technology Co., Ltd. (hereinafter referred to as “Hubei Huisheng”), a wholly-owned subsidiary, is the same party,
Together with the sponsor Haitong Securities Company Limited(600837) and Agricultural Bank Of China Limited(601288) Yingcheng sub branch signed the initial public offering agreement
Tripartite supervision agreement of the development bank on raising funds from shares.
Approved by the 11th meeting of the second board of directors of the company, on November 17, 2020, the company
Hubei Huisheng, together with the sponsor Haitong Securities Company Limited(600837) and China Merchants Bank Co.Ltd(600036) Wuhan Dongxihu sub branch
The four party supervision agreement on raising funds was signed. The contents of the above regulatory agreement are consistent with the regulatory agreement of Shenzhen Stock Exchange
There is no significant difference between the company and the company, and the company has strictly complied with the use of the raised funds.
Approved by the 21st Meeting of the second board of directors of the company, on December 23, 2021, the company
Hubei Huisheng, the sponsor Haitong Securities Company Limited(600837) and China Merchants Bank Co.Ltd(600036) Wuhan Dongxihu sub branch signed
The four party supervision agreement on raising funds provides for the company to raise funds by issuing convertible corporate bonds to unspecified objects
Storage and use of special users.
(III) storage of raised funds in special account
1. As of December 31, 2021, the storage of funds raised by the company’s initial public offering is as follows:
Below:
Initial deposit amount of raised funds closing date balance storage account name special account no. of deposit bank (Note 2, RMB (RMB) method)
Wuhan Hvsen Biotechnology Co.Ltd(300871) branch Hankou Bank Co., Ltd. 275010010010079390000 Shenzhen Guohua Network Security Technology Co.Ltd(000004) 07004184 current technology Co., Ltd. Wuchang Sub Branch Wuhan Hvsen Biotechnology Co.Ltd(300871) branch China Merchants Bank Co.Ltd(600036) Co., Ltd
Wuhan Dongxihu branch of Technology Co., Ltd. 127906203610605200000 Ping An Bank Co.Ltd(000001) 027529832 current bank
Wuhan Hvsen Biotechnology Co.Ltd(300871) Ke China Citic Bank Corporation Limited(601998) Co., Ltd. 81115010115007448
Technology Co., Ltd. Wuhan Branch Dongxi 41200000 China High-Speed Railway Technology Co.Ltd(000008) 957269037 current Lake sub branch
Wuhan Hvsen Biotechnology Co.Ltd(300871) Kezhong Agricultural Bank Of China Limited(601288) Co., Ltd
Yingcheng branch 1752530104 Cccg Real Estate Corporation Limited(000736) 977629273611773963710 current bank
Hubei Hvsen Biotechnology Co.Ltd(300871) Kezhong Agricultural Bank Of China Limited(601288) Co., Ltd
Yingcheng branch 1752530104 Apeloa Pharmaceutical Co.Ltd(000739) 3 – 11605770 current bank
Hubei Hvsen Biotechnology Co.Ltd(300871) Ke China Merchants Bank Co.Ltd(600036) Co., Ltd
Technology Co., Ltd. Wuhan Dongxihu branch 127906403310905 – 292003582 current bank
